On March 22, 2026, RetinalGenix Technologies Inc. announced the resignation of Michael Cory Zwerling, the Chief Financial Officer, effective immediately. This unexpected departure raises concerns regarding the company's financial leadership and stability. The resignation comes at a critical time as the company navigates its operational strategies and financial reporting obligations. The impact of this leadership change could affect investor confidence and the company's stock performance in the near term. The company has not yet announced a successor, which may further contribute to uncertainty among stakeholders. Investors will be closely monitoring how the company addresses this leadership gap and whether it can maintain its operational momentum without a CFO in place. The resignation was filed under item 5.02 of the Form 8-K, which pertains to the departure of directors or certain officers. RetinalGenix Technologies Inc. is incorporated in Delaware and has its headquarters in Petaluma, California. The company is classified as an emerging growth company, which may influence its reporting and compliance requirements moving forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.